ArticleBMC public health2025
Impact of COVID-19 vaccinations in India: a state-wise analysis.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEver since the emergence of COVID-19 and its consequent spread across continents, engulfing both advanced and developing nations, COVID-19 vaccine was considered to be the main weapon to curb the spread of the virus. The COVID-19 vaccination program in India started after the first wave of infections (March - December 2020) had almost subsided.
objectiveIn this work, the objective is to perform a state-wise analysis to assess the impact of vaccination in slowing down the spread of infections during the second COVID-19 wave (February - October 2021) in India. The prediction accuracy of the proposed model with the optimal lag length (in days) after including the impact of vaccination is evaluated and compared with a model without it. A total of 21 states are chosen for the analysis encompassing 97% of the Indian population.
methodsWe use the generalized Gompertz curve to study the COVID-19 outbreak. The generalized Gompertz model is then further modified to study the impact of vaccination to slow down the spread of COVID-19. The modified model considers the cumulative proportion of individuals having the first COVID-19 vaccine shot in each state as the explanatory variable.
resultsBy incorporating the impact of vaccination in the Generalized Gompertz Curves, it is seen that the visible impact of the first dose of the vaccination is observed after a lag of 20 days with 16 out of the 21 states showing the impact of vaccines in curbing the spread of COVID-19. However, in states like Telangana, West Bengal, Tamil Nadu, Rajasthan, and Kerala, we do not conclusively observe the impact of vaccination during the study period.
conclusionsUsing only COVID-19 infection cases and the vaccination data in the proposed model, we conclude that overall, the vaccination program effectively curbed the spread of COVID-19 in India.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.